High-dose therapy and growth factor mobilized peripheral blood progenitor cell support for responding patients with metastatic breast cancer.
作者信息
Stadtmauer E A, Hodi F S, Sickles C, Biggs D D, Mangan P, Buzby G, Zaleta E, Silberstein L
机构信息
Bone Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia.
出版信息
Prog Clin Biol Res. 1994;389:487-95.
PMID:7535458
Abstract
摘要
相似文献
1
High-dose therapy and growth factor mobilized peripheral blood progenitor cell support for responding patients with metastatic breast cancer.
Prog Clin Biol Res. 1994;389:487-95.
2
High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience.
Bone Marrow Transplant. 1998 Jan;21(2):127-32. doi: 10.1038/sj.bmt.1701066.
3
Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection.
Bone Marrow Transplant. 1998 Jan;21(2):123-6. doi: 10.1038/sj.bmt.1701058.
4
5
6
Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
Bone Marrow Transplant. 1994 Dec;14(6):877-84.
7
8
9
A novel high-dose chemotherapy protocol with autologous hematopoietic rescue in patients with metastatic breast cancer or recurrent non-Hodgkin's lymphoma.
Bone Marrow Transplant. 1997 May;19(10):983-8. doi: 10.1038/sj.bmt.1700783.
10
High-dose chemotherapy and autologous stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancer.
Clin Cancer Res. 1997 Feb;3(2):193-7.
Zotero 插件